Claritev Corporation ( CTEV) - Key Metrics
CTEV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $15.18 | -$3.49 | $5.46 | $3.22 |
| 2026Q1 | $14.66 | -$4.41 | -$2.74 | -$5.54 |
| 2025Q4 | $15 | -$4.90 | $4.03 | $2.21 |
| 2025Q3 | $14.92 | -$4.23 | $1.20 | -$0.99 |
| 2025Q2 | $14.68 | -$3.81 | $3.72 | $2.23 |
CTEV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.44 |
| 2026Q1 | 0% | -0.93 |
| 2025Q4 | 0% | -2.19 |
| 2025Q3 | 0% | -3.14 |
| 2025Q2 | 0% | -2.96 |
CTEV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 9.43% | 0% |
| 2026Q1 | -33.93% | 0% |
| 2025Q4 | 5.18% | 0% |
| 2025Q3 | -1.87% | 0% |
| 2025Q2 | 4.93% | 0% |
CTEV
Price: $35.98
52 week price:
Earnings Per Share: -17.18 USD
Exchange: NYQ
Sector: Healthcare
Industry: Health Information Services
Market Capitalization: 666.4 million